Serum N-Acetylneuraminic Acid Is Associated with Atrial Fibrillation and Left Atrial Enlargement
Table 1
Characteristics of the patients.
Characteristics
Control
AF
value
Demographics
No.
45
45
Age (years)
61.02 ± 10.11
61.80 ± 11.68
0.74
Male, %
26 (57.8)
26 (57.8)
1.00
Smoking, %
7 (15.6)
8 (17.8)
0.78
Hypertension, %
25 (55.6)
19 (42.2)
0.21
Diabetes, %
6 (13.3)
8 (17.8)
0.63
Biochemical testing
Triglycerides (mmol/L)
2.40 ± 1.56
2.04 ± 1.42
0.27
Total cholesterol (mmol/L)
4.43 ± 0.79
4.16 ± 0.88
0.14
LDL-C (mmol/L)
2.41 ± 0.62
2.23 ± 0.66
0.17
HDL-C (mmol/L)
1.15 ± 0.29
1.16 ± 0.32
0.85
Creatinine (μmol/L)
73.32 ± 19.92
72.81 ± 17.03
0.90
Uric acid (μmol/L)
397.00 ± 98.60
393.18 ± 102.72
0.86
Echocardiographic characteristics
Left atrial diameter (mm)
36.73 ± 5.20
40.20 ± 5.92
<0.01
Right atrial diameter (mm)
35.18 ± 3.55
35.78 ± 4.44
0.48
Left ventricular diameter (mm)
44.07 ± 5.65
44.13 ± 3.98
0.95
Right ventricular diameter (mm)
20.87 ± 3.08
20.76 ± 2.42
0.85
LV ejection fraction (%)
57.82 ± 7.12
57.27 ± 4.88
0.68
LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; LV: left ventricular. Values are mean ± SD or n (%). for significant differences.
